Mga Batayang Estadistika
| CIK | 1274913 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Inhibitex, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 27, 2012 |
FORM 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-50772 INHIBITEX, INC. (Exact name of registrant as specified in |
|
| February 16, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 13, 2012 Inhibitex, Inc. (Exact name of registrant as specified in its charter) Delaware 0-50772 742708737 (State or other jurisdiction of incorporation) (Commission |
|
| February 16, 2012 |
AMENDED AND RESTATED BYLAWS INHIBITEX, INC. A Delaware Corporation ARTICLE I Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF INHIBITEX, INC. A Delaware Corporation ARTICLE I OFFICES Section 1.1 Registered Office. The registered office of the corporation in the State of Delaware shall be located at 2711 Centerville Road, Suite 400, Wilmington Delaware 19808, in the County of New Castle. The name of the corporation’s registered agent at such address shall be Corporation Service C |
|
| February 16, 2012 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION INHIBITEX, INC. ARTICLE ONE Amended and Restated Certificate of Incorporation of Inhibitex, Inc. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INHIBITEX, INC. ARTICLE ONE The name of the corporation is Inhibitex, Inc. (hereinafter called the “Corporation”). ARTICLE TWO The address of the Corporation’s registered office in the state of Delaware is 2711 Centerville Road, Suite 400, Wilmington, New Castle Cou |
|
| February 15, 2012 |
- POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 Post-Effective Amendment No.1 to Form S-8 As filed with the Securities and Exchange Commission on February 15, 2012 Registration No. 333-167935 Registration No. 333-147335 Registration No. 333-129122 Registration No. 333-116446 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-167935 Post-Effective Amen |
|
| February 15, 2012 |
- POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 Post Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on February 15, 2012 Registration No. 333-149843 Registration No. 333-163132 Registration No. 333-165786 Registration No. 333-176352 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT NO. 333-149843 FORM S-3 REGISTRAT |
|
| February 15, 2012 |
- POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 Post Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on February 15, 2012 Registration No. 333-149843 Registration No. 333-163132 Registration No. 333-165786 Registration No. 333-176352 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT NO. 333-149843 FORM S-3 REGISTRAT |
|
| February 15, 2012 |
- POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 Post-Effective Amendment No.1 to Form S-8 As filed with the Securities and Exchange Commission on February 15, 2012 Registration No. 333-167935 Registration No. 333-147335 Registration No. 333-129122 Registration No. 333-116446 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-167935 Post-Effective Amen |
|
| February 15, 2012 |
- POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 Post Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on February 15, 2012 Registration No. 333-149843 Registration No. 333-163132 Registration No. 333-165786 Registration No. 333-176352 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT NO. 333-149843 FORM S-3 REGISTRAT |
|
| February 15, 2012 |
- POST EFFECTIVE AMENDMENT NO.1 TO FORM S-3 Post Effective Amendment No.1 to Form S-3 As filed with the Securities and Exchange Commission on February 15, 2012 Registration No. 333-149843 Registration No. 333-163132 Registration No. 333-165786 Registration No. 333-176352 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT NO. 333-149843 FORM S-3 REGISTRATI |
|
| February 15, 2012 |
- POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 Post-Effective Amendment No.1 to Form S-8 As filed with the Securities and Exchange Commission on February 15, 2012 Registration No. 333-167935 Registration No. 333-147335 Registration No. 333-129122 Registration No. 333-116446 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-167935 Post-Effective Amen |
|
| February 15, 2012 |
- POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 Post-Effective Amendment No.1 to Form S-8 As filed with the Securities and Exchange Commission on February 15, 2012 Registration No. 333-167935 Registration No. 333-147335 Registration No. 333-129122 Registration No. 333-116446 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-167935 Post-Effective Amen |
|
| February 13, 2012 |
INHX / Inhibitex, Inc. / BRISTOL MYERS SQUIBB CO - AMENDMENT NO. 6 TO SCHEDULE TO Amendment No. 6 to Schedule TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 5 INHIBITEX, INC. (Name of Subject Company (Issuer)) INTA ACQUISITION CORPORATION (Offeror) A Wholly Owned Subsidiary of BRISTOL-MYERS SQUIBB COMPANY (Offeror) (Names of Fili |
|
| February 13, 2012 |
- AMENDMENT NO. 6 TO SCHEDULE 14D-9 Amendment No. 6 to Schedule 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 6 to SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Inhibitex, Inc. (Name of Subject Company) Inhibitex, Inc. (Names of Persons Filing Statement) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securi |
|
| February 13, 2012 |
Press Release Exhibit (a)(13) Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc. |
|
| February 13, 2012 |
INHX / Inhibitex, Inc. / NEW ENTERPRISE ASSOCIATES 10 L P - INHIBITEX Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Inhibitex, Inc. (Name of Issuer) Common Stock, $.001 par value (Title of Class of Securities) 45719T10 3 (CUSIP Number) Louis S. Citron, Esq. New Enterprise Associates 1954 Greenspring Drive Timonium, MD 21093 (410) 842-4000 (Name, Address and Telephone |
|
| February 6, 2012 |
- AMENDMENT NO. 5 TO SCHEDULE 14D-9 Amendment No. 5 to Schedule 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 5 to SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Inhibitex, Inc. (Name of Subject Company) Inhibitex, Inc. (Names of Persons Filing Statement) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securi |
|
| February 6, 2012 |
INHX / Inhibitex, Inc. / BRISTOL MYERS SQUIBB CO - AMENDMENT NO. 4 TO SCHEDULE TO Amendment No. 4 to Schedule TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 4 INHIBITEX, INC. (Name of Subject Company (Issuer)) INTA ACQUISITION CORPORATION (Offeror) A Wholly Owned Subsidiary of BRISTOL-MYERS SQUIBB COMPANY (Offeror) (Names of Fili |
|
| February 3, 2012 |
INHX / Inhibitex, Inc. / BRISTOL MYERS SQUIBB CO - AMENDMENT NO. 3 TO SCHEDULE TO Amendment No. 3 to Schedule TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 3 INHIBITEX, INC. (Name of Subject Company (Issuer)) INTA ACQUISITION CORPORATION (Offeror) A Wholly Owned Subsidiary of BRISTOL-MYERS SQUIBB COMPANY (Offeror) (Names of Fili |
|
| February 3, 2012 |
- AMENDMENT NO. 4 TO SCHEDULE 14D-9 Amendment No. 4 to Schedule 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 4 to SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Inhibitex, Inc. (Name of Subject Company) Inhibitex, Inc. (Names of Persons Filing Statement) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securi |
|
| February 3, 2012 |
Press Release Exhibit (a)(12) Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibitex, Inc. |
|
| February 1, 2012 |
Amendment No. 3 to SC 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Inhibitex, Inc. (Name of Subject Company) Inhibitex, Inc. (Names of Persons Filing Statement) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) |
|
| January 27, 2012 |
- AMENDNMENT NO. 2 TO SCHEDULE 14D-9 Amendnment No. 2 to Schedule 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Inhibitex, Inc. (Name of Subject Company) Inhibitex, Inc. (Names of Persons Filing Statement) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Secur |
|
| January 27, 2012 |
Exhibit (e)(16) IN THE SUPERIOR COURT OF FULTON COUNTY STATE OF GEORGIA JEREMY ALBER, Individually and on Behalf ) Civil Action No. |
|
| January 27, 2012 |
INHX / Inhibitex, Inc. / BRISTOL MYERS SQUIBB CO - AMENDMENT NO. 2 TO SCHEDULE TO Amendment No. 2 to Schedule TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 2 INHIBITEX, INC. (Name of Subject Company (Issuer)) INTA ACQUISITION CORPORATION (Offeror) A Wholly Owned Subsidiary of BRISTOL-MYERS SQUIBB COMPANY (Offeror) (Names of Fili |
|
| January 27, 2012 |
Exhibit (e)(17) IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE CHARLES C. OSBORNE, JR. and ) HORTENSIA D. OSBORNE, Individually and ) On Behalf of All Others Similarly Situated, ) ) Plaintiffs, ) ) v. ) C.A. No. 7169-VCN ) INHIBITEX, INC., M. JAMES BARRETT, ) RUSSELL M. MEDFORD, A. KEITH ) WILLARD, GABRIELE M. CERRONE, ) RUSSELL H. PLUMB, MICHAEL A. HENOS, ) MARC L. PREMINGER, CHRISTOPHER ) MCG |
|
| January 27, 2012 |
Class Action Complaint dated January 25, 2012 Exhibit (e)(18) UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF GEORGIA ATLANTA DIVISION FERDINAND ALVAREZ, individually ) and on behalf of all others similarly ) situated, ) ) Plaintiff, ) CIVIL ACTION NO. |
|
| January 19, 2012 |
INHX / Inhibitex, Inc. / BRISTOL MYERS SQUIBB CO - AMENDMENT NO. 1 Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 1 INHIBITEX, INC. (Name of Subject Company (Issuer)) INTA ACQUISITION CORPORATION (Offeror) A Wholly Owned Subsidiary of BRISTOL-MYERS SQUIBB COMPANY (Offeror) (Names of Filing Persons (ide |
|
| January 19, 2012 |
- SCHEDULE 14D-9 AMENDMENT NO.1 Schedule 14d-9 Amendment No.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Inhibitex, Inc. (Name of Subject Company) Inhibitex, Inc. (Names of Persons Filing Statement) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities |
|
| January 19, 2012 |
Class Action Complaint dated January 13, 2012 (John P. Hegarty v. Inhibitex) Exhibit (a)(8) IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE JOHN P. HEGARTY, Individually and On ) Behalf of All Others Similarly Situated, ) ) Plaintiff, ) ) v. ) ) Civil Action No. INHIBITEX, INC., MICHAEL A. HENOS, ) M. JAMES BARRETT, GABRIELE M. ) CERRONE, CHRIS MCGUIGAN, ) RUSSELL M. MEDFORD, RUSSELL H. ) PLUMB, |
|
| January 17, 2012 |
Class action complaint dated January 12, 2012 Exhibit (e)(14) IN THE SUPERIOR COURT OF FULTON COUNTY, GEORGIA 136 Pryor Street, Room C-103, Atlanta, Georgia 30303 SUMMONS JEREMY ALBER, Individually and on Behalf of ) ) ) ) ) ) ) ) ) ) ) ) All Others Similarly Situated, Plaintiff, Civil Action No. |
|
| January 17, 2012 |
EX-99.(A)(9) 2 d282223dex99a9.htm LETTER, DATED JANUARY 17, 2012, TO THE STOCKHOLDERS OF INHIBITEX, INC. Exhibit (a)(9) January 17, 2012 Dear Inhibitex Stockholders: We are pleased to report that Inhibitex, Inc. (the “Company”) has entered into an Agreement and Plan of Merger, dated as of January 7 , 2012 (the “Merger Agreement”), with Bristol-Myers Squibb Company (“Parent”) and Inta Acquisition C |
|
| January 17, 2012 |
Schedule 14D-9 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 13, 2012 |
Notice of Guaranteed Delivery Exhibit 99(a)(1)(C) NOTICE OF GUARANTEED DELIVERY For Tender of Shares of Common Stock of INHIBITEX, INC. |
|
| January 13, 2012 |
Letter of Transmittal Exhibit 99(a)(1)(B) LETTER OF TRANSMITTAL To Tender Shares of Common Stock of INHIBITEX, INC. |
|
| January 13, 2012 |
EX-99.A.1.A 2 d281805dex99a1a.htm OFFER TO PURCHASE Exhibit 99(a)(1)(A) Offer to Purchase for Cash All Outstanding Shares of Common Stock of INHIBITEX, INC. at $26.00 Net Per Share by INTA ACQUISITION CORPORATION, a wholly–owned subsidiary of BRISTOL–MYERS SQUIBB COMPANY THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON FRIDAY, FEBRUARY 10, 2012, UNLESS THE OFFE |
|
| January 13, 2012 |
Bristol-Myers Squibb Begins Tender Offer to Acquire Inhibitex, Inc. Exhibit 99(a)(5) Bristol-Myers Squibb Begins Tender Offer to Acquire Inhibitex, Inc. |
|
| January 13, 2012 |
Exhibit 99(a)(1)(E) Offer To Purchase For Cash All Outstanding of Shares of Common Stock of INHIBITEX, INC. |
|
| January 13, 2012 |
Broker Letter Exhibit 99(a)(1)(D) Offer To Purchase For Cash All Outstanding of Shares of Common Stock of INHIBITEX, INC. |
|
| January 13, 2012 |
Class Action Complaint Exhibit 99(a)(6) IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE CHARLES C. |
|
| January 13, 2012 |
Joint Filing Agreement Exhibit 3 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby (i) agree to the joint filing with all other Reporting Persons (as such term is defined in the statement on Schedule 13D described below) of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, par value $0. |
|
| January 13, 2012 |
Summary Advertisement Exhibit (a)(1)(G) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below). |
|
| January 13, 2012 |
INHX / Inhibitex, Inc. / BRISTOL MYERS SQUIBB CO - SCHEDULE 13D Activist Investment Schedule 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 Inhibitex, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 45719T103 (CUSIP Numbe |
|
| January 13, 2012 |
Schedule TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 INHIBITEX, INC. (Name of Subject Company (Issuer)) INTA ACQUISITION CORPORATION (Offeror) A Wholly-Owned Subsidiary of BRISTOL-MYERS SQUIBB COMPANY (Offeror) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title o |
|
| January 10, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 7, 2012 Inhibitex, Inc. (Exact name of registrant as specified in its charter) Delaware 0-50772 742708737 (State or other jurisdiction of incorporation) (Commission F |
|
| January 10, 2012 |
Tender and Support Agreement, dated as of January 7, 2012 Exhibit 10.1 TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of January 7, 2012, is by and among Bristol-Myers Squibb Company, a Delaware corporation (“Parent”), Inta Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (“Sub”), Inhibitex, Inc., a Delaware corpor |
|
| January 10, 2012 |
INHX / Inhibitex, Inc. / NEW ENTERPRISE ASSOCIATES 10 L P - INHIBITEX Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Inhibitex, Inc. (Name of Issuer) Common Stock, $.001 par value (Title of Class of Securities) 45719T10 3 (CUSIP Number) Louis S. Citron, Esq. New Enterprise Associates 1954 Greenspring Drive Timonium, MD 21093 (410) 842-4000 (Name, Address and Telephone |
|
| January 10, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 INHIBITEX, INC. (Name of Subject Company (Issuer)) INTA ACQUISITION CORPORATION (Offeror) A Wholly Owned Subsidiary of BRISTOL-MYERS SQUIBB COMPANY (Offeror) (Names of Filing Persons (identifying status as offeror, issu |
|
| January 10, 2012 |
Agreement and Plan of Merger Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER Dated as of January 7, 2012 Among BRISTOL-MYERS SQUIBB COMPANY, INTA ACQUISITION CORPORATION and INHIBITEX, INC. Table of Contents Page ARTICLE I The Offer 2 Section 1.01. The Offer 2 Section 1.02. Company and Sub Actions 5 Section 1.03. Directors 6 Section 1.04. The Top-Up Option 7 Section 1.05. Short Form Mer |
|
| January 9, 2012 |
SC14D9C 1 d279473dsc14d9c.htm SCHEDULE 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 INHIBITEX, INC. (Name of Subject Company) INHIBITEX, INC. (Name of Person Filing Statement) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of S |
|
| January 9, 2012 |
Schedule TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 INHIBITEX, INC. (Name of Subject Company (Issuer)) INTA ACQUISITION CORPORATION (Offeror) A Wholly Owned Subsidiary of BRISTOL-MYERS SQUIBB COMPANY (Offeror) (Names of Filing Persons (identifying status as o |
|
| January 9, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported): January 9, 2012 (January 7, 2012) BRISTOL-MYERS SQUIBB COMPANY (Exact Name of Registrant as Specified in its Charter) Delaware 1-1136 22-079-0350 (State or Other Jurisdiction |
|
| January 9, 2012 |
Bristol-Myers Squibb to Acquire Inhibitex EX-99.1 2 d279471dex991.htm JOINT PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY AND INHIBITEX Exhibit 99.1 Bristol-Myers Squibb to Acquire Inhibitex • Strategic Acquisition Supports Long-Term Growth Potential of the Company • Builds on Company’s Strong Legacy and Commitment in Virology • Enhances Company’s Broad HCV Portfolio with Addition of INX-189, a potent NS5B Nucleotide (NEW YORK & PRINCETON |
|
| January 9, 2012 |
Schedule 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 INHIBITEX, INC. (Name of Subject Company) INHIBITEX, INC. (Name of Person Filing Statement) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 45719T103 (CUSIP Nu |
